Astellas’ Clot Drug Raises Bleeding in Heart Study

An experimental anti-clotting drug from Japan’s Astellas increased bleeding two- to four-fold in a mid-stage clinical study of heart patients, raising questions about its role in treating those with acute coronary problems.
Reuters